27 related articles for article (PubMed ID: 36735630)
1. PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma.
Feng G; Chen C; Luo Y
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859611
[TBL] [Abstract][Full Text] [Related]
2. KIAA1429 Promotes Nasopharyngeal Carcinoma Progression by Mediating m6A Modification of PTGS2.
Wu L; Zhou Y; Fu J
Crit Rev Immunol; 2023; 43(4):15-27. PubMed ID: 37830191
[TBL] [Abstract][Full Text] [Related]
3. METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.
Liu S; Hausmann S; Carlson SM; Fuentes ME; Francis JW; Pillai R; Lofgren SM; Hulea L; Tandoc K; Lu J; Li A; Nguyen ND; Caporicci M; Kim MP; Maitra A; Wang H; Wistuba II; Porco JA; Bassik MC; Elias JE; Song J; Topisirovic I; Van Rechem C; Mazur PK; Gozani O
Cell; 2019 Jan; 176(3):491-504.e21. PubMed ID: 30612740
[TBL] [Abstract][Full Text] [Related]
4. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis.
Sun Y; Yi H; Zhang PF; Li MY; Li C; Li F; Peng F; Feng XP; Yang YX; Yang F; Xiao ZQ; Chen ZC
FEBS Lett; 2007 Jan; 581(1):131-9. PubMed ID: 17184779
[TBL] [Abstract][Full Text] [Related]
5. GTSE1 promotes nasopharyngeal carcinoma proliferation and angiogenesis by upregulating STMN1.
Dong J; Chen J; Wu Y; Yan J
Cell Div; 2024 May; 19(1):16. PubMed ID: 38698443
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the biochemical activity and tumor-promoting role of the dual protein methyltransferase METL-13/METTL13 in Caenorhabditis elegans.
Engelfriet ML; Małecki JM; Forsberg AF; Falnes PØ; Ciosk R
PLoS One; 2023; 18(6):e0287558. PubMed ID: 37347777
[TBL] [Abstract][Full Text] [Related]
7. Correction to LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
Cancer Sci; 2024 Feb; 115(2):687-689. PubMed ID: 38087442
[No Abstract] [Full Text] [Related]
8. Retraction Note: METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion.
Zhang Z; Zhang G; Kong C; Zhan B; Dong X; Man X
Sci Rep; 2023 Jul; 13(1):11916. PubMed ID: 37488192
[No Abstract] [Full Text] [Related]
9. Optimizing purification and activity assays of N-terminal methyltransferase complexes.
Parker HV; Tooley JG; Schaner Tooley CE
Methods Enzymol; 2023; 684():71-111. PubMed ID: 37230594
[TBL] [Abstract][Full Text] [Related]
10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
11. LncRNA MINCR regulates irradiation resistance in nasopharyngeal carcinoma cells via the microRNA-223/ZEB1 axis.
Zhong Q; Chen Y; Chen Z
Cell Cycle; 2020 Jan; 19(1):53-66. PubMed ID: 31760895
[TBL] [Abstract][Full Text] [Related]
12. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.
Li L; Zheng YL; Jiang C; Fang S; Zeng TT; Zhu YH; Li Y; Xie D; Guan XY
Cell Death Differ; 2019 Nov; 26(11):2268-2283. PubMed ID: 30778199
[TBL] [Abstract][Full Text] [Related]
13. Structure, Activity and Function of the Dual Protein Lysine and Protein N-Terminal Methyltransferase METTL13.
Jakobsson ME
Life (Basel); 2021 Oct; 11(11):. PubMed ID: 34832997
[TBL] [Abstract][Full Text] [Related]
14. METTL13 promotes nasopharyngeal carcinoma progression through regulating the ZEB1/TPT1 axis.
Ni H; Liang C; Zhou Z; Jiang B; Li Y; Shang H; Yu X
J Gene Med; 2023 May; 25(5):e3476. PubMed ID: 36735630
[TBL] [Abstract][Full Text] [Related]
15. miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1.
Tang L; Xiang Y; Zhou J; Li T; Jia T; Du G
Braz J Otorhinolaryngol; 2024; 90(1):101358. PubMed ID: 37989078
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
